Preparation of 177Lu-labeled oxine in lipiodol as a possible agent for therapy of hepatocellular carcinoma: A preliminary animal study
dc.contributor.author | Subramanian, S. | |
dc.contributor.author | Das, T. | |
dc.contributor.author | Chakraborty, S. | |
dc.contributor.author | Sarma, H. D. | |
dc.contributor.author | Banerjee, S. | |
dc.contributor.author | Samuel, G. | |
dc.contributor.author | Venkatesh, M. | |
dc.date.accessioned | 2011-03-30T05:48:56Z | |
dc.date.available | 2011-03-30T05:48:56Z | |
dc.date.issued | 2010 | |
dc.format.extent | 4356 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.source | Cancer Biotherapy and Radiopharmaceuticals, 2010. Vol. 25 (5): pp. 539-543 | en |
dc.identifier.uri | http://hdl.handle.net/123456789/4415 | |
dc.language.iso | en | en |
dc.subject | hepatocellular carcinoma | en |
dc.subject | lipiodol | en |
dc.subject | 177Lu | en |
dc.subject | radioembolization | en |
dc.title | Preparation of 177Lu-labeled oxine in lipiodol as a possible agent for therapy of hepatocellular carcinoma: A preliminary animal study | en |
dc.type | Article | en |